314 related articles for article (PubMed ID: 18456741)
1. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
2. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
[No Abstract] [Full Text] [Related]
3. Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Oberg K; Akerström G; Rindi G; Jelic S;
Ann Oncol; 2010 May; 21 Suppl 5():v223-7. PubMed ID: 20555086
[No Abstract] [Full Text] [Related]
4. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2009 May; 20 Suppl 4():150-3. PubMed ID: 19454440
[No Abstract] [Full Text] [Related]
5. [Gastrointestinal and pancreatic neuroendocrine tumors].
Salazar R; Villabona C; Fabregat J
Med Clin (Barc); 2006 Jul; 127(6):227-31. PubMed ID: 16938245
[No Abstract] [Full Text] [Related]
6. Foreword: Gastroenteropancreatic system and its tumors: Part 2.
LeRoith D
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):xiii-xv. PubMed ID: 21349407
[No Abstract] [Full Text] [Related]
7. Preface: Gastroenteropancreatic system and its tumors: Part 2.
Vinik AI
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):xvii-xviii. PubMed ID: 21349408
[No Abstract] [Full Text] [Related]
8. Current Concepts in the Management of GEP-NETs: Introduction.
Iyer R
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):3-4. PubMed ID: 27167990
[No Abstract] [Full Text] [Related]
9. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).
Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R
Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156
[TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pavel M; Öberg K; Falconi M; Krenning EP; Sundin A; Perren A; Berruti A;
Ann Oncol; 2020 Jul; 31(7):844-860. PubMed ID: 32272208
[No Abstract] [Full Text] [Related]
11. [Neuroendocrine tumors of the gastroenteropancreatic system. An interdisciplinary challenge].
Beuschlein F; Reincke M
Internist (Berl); 2012 Feb; 53(2):129-30. PubMed ID: 22457878
[No Abstract] [Full Text] [Related]
12. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
Tsimmerman IaS
Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
[TBL] [Abstract][Full Text] [Related]
13. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
Kos-Kudła B;
Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
[No Abstract] [Full Text] [Related]
14. Natural history and outcome in Chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis.
Chan DT; Luk AO; So WY; Kong AP; Chow FC; Ma RC; Lo AW
BMC Endocr Disord; 2016 Feb; 16():12. PubMed ID: 26911576
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
[No Abstract] [Full Text] [Related]
16. Neuroendocrine tumors in children and young adults: rare or not so rare.
Sarvida ME; O'Dorisio MS
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):65-80, vii. PubMed ID: 21349411
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine tumors in children and young adults.
Khanna G; O'Dorisio SM; Menda Y; Kirby P; Kao S; Sato Y
Pediatr Radiol; 2008 Mar; 38(3):251-9, quiz 358-9. PubMed ID: 17906857
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors.
Lee JE; Evans DB
Cancer Treat Res; 1997; 90():227-38. PubMed ID: 9367086
[No Abstract] [Full Text] [Related]
19. [The up-to-date review of pancreatic and gastrointestinal neuroendocrine tumors].
Ito T; Hijioka M; Lee L; Kawabe K; Nakamura K; Igarashi H
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2255-62. PubMed ID: 25482900
[No Abstract] [Full Text] [Related]
20. Recurrence in Resected Gastroenteropancreatic Neuroendocrine Tumors.
Singh S; Chan DL; Moody L; Liu N; Fischer HD; Austin PC; Segelov E
JAMA Oncol; 2018 Apr; 4(4):583-585. PubMed ID: 29543939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]